News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Somatostatin-receptor scintigraphy in primary breast cancer
- Increased expression of the prolactin receptor is associated with malignant laryngeal tumors
- Effects of melatonin regulating on growth and development of hard tissues
- Biological significance of prolactin in gynecologic cancers
- Effect of retinoids on the growth of squamous cell carcinoma of the palate in rats
- Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5
- Vitamin E induces morphological differentiation and increases the effect of ionizing radiation on neuroblastoma cells in culture
- A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis
- The effect of retinoids on premalignant oral lesions: focus on topical therapy
- Vitamin E inhibition of hamster buccal pouch carcinogenesis. A gross, histologic, and ultrastructural study
- Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator
- Prolactin and cancer: Has the orphan finally found a home?
- Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues
- Protective effect of vitamin E against immunosuppression induced by adriamycin, mitomycin C and 5-fluorouracil in mice
- Beneficial properties of melatonin in an experimental model of pancreatic cancer
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- About melatonin - 1996
- Bibliography
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Vademecum
- Frequently Asked Questions
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma